Martin Dewhurst
Board Member
Turn Therapeutics Inc. (TTRX)Equibles does not estimate personal net worth.
Get an email with a short summary when Turn Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.
Get TTRX alertsAbout Martin Dewhurst
Martin Dewhurst is recorded as Board Member at Turn Therapeutics Inc. (TTRX) since January 7, 2026. The newest filing on record that lists Martin Dewhurst as Board Member at Turn Therapeutics Inc. (TTRX) is dated October 19, 2026. Turn Therapeutics Inc. reported in an 8-K filed January 7, 2026 that Martin Dewhurst was appointed independent Class III director, effective January 7, 2026. Turn Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Turn Therapeutics Inc. includes Bradley Burnam (CEO and Board Member), Zuraiz Chaudhary (CFO), Andrew Gengos (Board Member) and 3 others.
“On January 7, 2026, the board of directors (the "Board") of Turn Therapeutics Inc. (the "Company") enlarged the Board from five to six members and appointed Martin Dewhurst to the Board, effective immediately.”
Affiliation history
-
Current
2026-01-07–present
Last confirmed October 19, 2026
Company network
Leadership on record at Turn Therapeutics Inc.
- Bradley Burnam CEO, Board Member
- Zuraiz Chaudhary CFO
- Andrew Gengos Board Member
- Arthur Golden Board Member
- Dr. Kent Kester Board Member
- Dr. Neil Ghodadra Board Member